GGrantIndex
Sort

23,748 grants matching melanoma

Engineered Ensemble Nanoimmunotherapies for Cancer

$422,156
Rohan Fernandes · George Washington University · R37 · FY2020 · CA

Role of exosomal SPHK1 in ovarian cancer progression

$422,127
Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2024 · CA

Role of Formylpeptide Receptors in Host Defense

$422,080
Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface

$422,043
Forest M White · Massachusetts Institute Of Technology · U54 · FY2024 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$422,042
Vanderbilt University · U10 · FY2001 · CA

Phenotypic variability within isogenic population of lymphocytes

$421,972
Gregoire Altan-Bonnet · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy

$421,954
Udai S Kammula · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$421,699
University Of Pennsylvania · U10 · FY2004 · CA

Impact of senescence on T-cell function and immunotherapeutic response

$421,651
Christin E Burd · Ohio State University · R01 · FY2020 · AG

Effect of the aged microenvironment on tumor dormancy

$421,585
Ashani T Weeraratna · Wistar Institute · R01 · FY2019 · CA

Selective inhibition of nitric oxide synthase for multiple indications

$421,538
Richard B Silverman · Northwestern University · R01 · FY2017 · GM

Shared Resource: Therapeutic Manufacturing

$421,498
Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2018 · CA

Shared Resource: Therapeutic Manufacturing

$421,497
Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2019 · CA

Statistical Methods for Data Integration and Applications to Genome-wide Association Studies

$421,361
Nilanjan Chatterjee · Johns Hopkins University · R01 · FY2024 · HG

COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS

$421,346
William Marland Old · University Of Colorado · R01 · FY2008 · CA

Shared Resource: Therapeutic Manufacturing

$421,294
Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2016 · CA

Impact of senescence on T-cell function and immunotherapeutic response

$421,203
Christin E Burd · Ohio State University · R01 · FY2021 · AG

Impact of senescence on T-cell function and immunotherapeutic response

$421,203
Christin E Burd · Ohio State University · R01 · FY2022 · AG

Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy

$420,763
Gary D Kao · University Of Pennsylvania · R01 · FY2019 · CA

Establishing the Preclinical Model for Metastatic Melanoma

$420,730
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma

$420,670
Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology

$420,583
K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2025 · CA

Molecular Epidemiology of Non-Melanoma Skin Cancer

$420,475
Harvard University (Sch Of Public Hlth) · R01 · FY2003 · CA

Cancer Biology in the Zebrafish

$420,375
Leonard I Zon · Boston Children'S Hospital · R01 · FY2020 · CA

Cancer Biology in the Zebrafish

$420,375
Leonard I Zon · Boston Children'S Hospital · R01 · FY2021 · CA